KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $22.4 billion.

  • Cvs Health's Accumulated Expenses rose 757.81% to $22.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $22.4 billion, marking a year-over-year increase of 757.81%. This contributed to the annual value of $22.4 billion for FY2025, which is 757.81% up from last year.
  • As of Q4 2025, Cvs Health's Accumulated Expenses stood at $22.4 billion, which was up 757.81% from $23.4 billion recorded in Q3 2025.
  • Cvs Health's Accumulated Expenses' 5-year high stood at $23.5 billion during Q4 2023, with a 5-year trough of $14.3 billion in Q1 2021.
  • Its 5-year average for Accumulated Expenses is $20.1 billion, with a median of $21.0 billion in 2024.
  • As far as peak fluctuations go, Cvs Health's Accumulated Expenses surged by 2946.03% in 2023, and later crashed by 1150.33% in 2024.
  • Over the past 5 years, Cvs Health's Accumulated Expenses (Quarter) stood at $17.7 billion in 2021, then increased by 6.08% to $18.7 billion in 2022, then grew by 25.45% to $23.5 billion in 2023, then decreased by 11.5% to $20.8 billion in 2024, then increased by 7.58% to $22.4 billion in 2025.
  • Its Accumulated Expenses stands at $22.4 billion for Q4 2025, versus $23.4 billion for Q3 2025 and $23.1 billion for Q2 2025.